Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer

被引:31
作者
He, Ping [1 ]
Sun, Hua [2 ]
Jian, Xi-Xian [1 ]
Chen, Qiao-Hong [1 ]
Chen, Dong-Lin [1 ]
Liu, Geng-Tao [2 ]
Wang, Feng-Peng [1 ]
机构
[1] Sichuan Univ, W China Coll Pharm, Dept Chem Med Nat Prod, Chengdu 610041, Peoples R China
[2] Chinese Acad Med Sci, Inst Mat Med, Dept Pharmacol, Beijing 100050, Peoples R China
关键词
bisbenzylisoquinoline alkaloids; multidrug resistance; P-glycoprotein; P-GLYCOPROTEIN; DRUG-RESISTANCE; TUMOR-CELLS; IN-VITRO; TETRANDRINE; REVERSAL; TRANSPORTERS; INHIBITION; CARCINOMA; VIVO;
D O I
10.1080/10286020.2012.680443
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
A series of new bisbenzylisoquinoline alkaloids was partially synthesized from tetrandrine and fangchinoline and evaluated for their ability to reverse P-glycoprotein-mediated multidrug resistance (MDR) in cancer cells. All the test compounds increased the intracellular accumulation rate of rhodamine 123 in MDR cells (Bel7402 and HCT8), and most exhibited more potent MDR-reversing activity relative to the reference compound verapamil. Compounds 8, 10, 13, and 14 enhanced intracellular accumulation of doxorubicin in Bel7402 and HCT8 cells.
引用
收藏
页码:564 / 576
页数:13
相关论文
共 29 条
[1]
Chen LM, 2009, ANTICANCER RES, V29, P4597
[2]
The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein [J].
Choi, SU ;
Park, SH ;
Kim, KH ;
Choi, EJ ;
Kim, S ;
Park, WK ;
Zhang, YH ;
Kim, HS ;
Jung, NP ;
Lee, CO .
ANTI-CANCER DRUGS, 1998, 9 (03) :255-261
[3]
Bisbenzylisoquinolines as modulators of chloroquine resistance in Plasmodium falciparum and multidrug resistance in tumor cells [J].
Frappier, F ;
Jossang, A ;
Soudon, J ;
Calvo, F ;
Rasoanaivo, P ;
RatsimamangaUrverg, S ;
Saez, J ;
Schrevel, J ;
Grellier, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1476-1481
[4]
The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinorna MCF-7/adr cells [J].
Fu, LW ;
Zhang, YM ;
Liang, YJ ;
Yang, XP ;
Pan, QC .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (03) :418-426
[5]
Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance [J].
Fu, LW ;
Liang, YJ ;
Deng, LW ;
Ding, Y ;
Chen, LM ;
Ye, YL ;
Yang, XP ;
Pan, QC .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (04) :349-356
[6]
Multidrug resistance in cancer: Role of ATP-dependent transporters [J].
Gottesman, MM ;
Fojo, T ;
Bates, SE .
NATURE REVIEWS CANCER, 2002, 2 (01) :48-58
[7]
GUHA KP, 1979, LLOYDIA, V42, P1
[8]
Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine [J].
Jin, J ;
Wang, FP ;
Wei, HL ;
Liu, GT .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (02) :179-188
[9]
An overview of cancer multidrug resistance: a still unsolved problem [J].
Lage, H. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (20) :3145-3167
[10]
A Novel Calmodulin Antagonist O-(4-Ethoxyl-Butyl)-Berbamine Overcomes Multidrug Resistance in Drug-Resistant MCF-7/ADR Breast Carcinoma Cells [J].
Liu, Rong ;
Zhang, Yanjun ;
Chen, Yanhong ;
Qi, Jing ;
Ren, Simei ;
Xushi, Ming Yang ;
Yang, Chunzheng ;
Zhu, Huifang ;
Xiong, Dongsheng .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (07) :3266-3275